WealthShield Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$713K Buy
5,928
+61
+1% +$7.04K 0.08% 215
2025
Q4
$618K Buy
5,867
+1,360
+30% +$128K 0.07% 225
2025
Q3
$378K Buy
4,507
+26
+0.6% +$2.14K 0.04% 258
2025
Q2
$355K Sell
4,481
-32,197
-88% -$2.56M 0.04% 263
2025
Q1
$3.31M Buy
36,678
+16,447
+81% +$1.54M 0.42% 66
2024
Q4
$2.03M Sell
20,231
-6,439
-24% -$664K 0.29% 98
2024
Q3
$3.05M Buy
26,670
+1,838
+7% +$218K 0.41% 71
2024
Q2
$3.09M Buy
24,832
+1,238
+5% +$159K 0.47% 60
2024
Q1
$3.13M Buy
23,594
+681
+3% +$83.9K 0.51% 52
2023
Q4
$2.52M Buy
22,913
+1,987
+9% +$206K 0.41% 67
2023
Q3
$2.17M Buy
20,926
+2,514
+14% +$271K 0.33% 83
2023
Q2
$2.14M Buy
18,412
+295
+2% +$33.5K 0.32% 79
2023
Q1
$1.94M Sell
18,117
-3,258
-15% -$352K 0.31% 85
2022
Q4
$2.39M Buy
21,375
+203
+1% +$20.8K 0.46% 57
2022
Q3
$1.84M Buy
21,172
+1,901
+10% +$170K 0.36% 74
2022
Q2
$1.77M Buy
19,271
+1,634
+9% +$145K 0.35% 72
2022
Q1
$1.46M Buy
17,637
+5,971
+51% +$471K 0.23% 107
2021
Q4
$894K Buy
11,666
+628
+6% +$50K 0.15% 148
2021
Q3
$829K Buy
11,038
+785
+8% +$59.7K 0.22% 99
2021
Q2
$797K Buy
10,253
+1,568
+18% +$117K 0.12% 121
2021
Q1
$639K Buy
8,685
+1,625
+23% +$120K 0.11% 129
2020
Q4
$552K Buy
7,060
+1,349
+24% +$103K 0.1% 158
2020
Q3
$452K Buy
5,711
+669
+13% +$52.4K 0.16% 140
2020
Q2
$372K Buy
5,042
+735
+17% +$55.3K 0.17% 135
2020
Q1
$316K Sell
4,307
-389
-8% -$30.6K 0.19% 113
2019
Q4
$408K Buy
4,696
+147
+3% +$12.1K 0.2% 114
2019
Q3
$365K Buy
4,549
+578
+15% +$46.3K 0.19% 116
2019
Q2
$318K Sell
3,971
-339
-8% -$26K 0.18% 110
2019
Q1
$344K Sell
4,310
-989
-19% -$74K 0.19% 95
2018
Q4
$387K Buy
+5,299
New +$374K 0.26% 74

Other funds holding MRK

WealthShield Partners's MRK Position: Q1 2026 in Review

WealthShield Partners increased its Merck (MRK) stake by 1% in Q1 2026, buying an estimated $7.04K and bringing the position to 5,928 shares worth $713K. The position accounts for 0.08% of the portfolio, ranked #215.

WealthShield Partners first reported a position in MRK in Q4 2018 and has held it in 30 quarters since. The position peaked at $3.31M in Q1 2025. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • WealthShield Partners held 5,928 shares of Merck worth $713K as of Q1 2026.
  • WealthShield Partners bought 61 Merck shares in Q1 2026, an estimated $7.04K.
  • Merck made up 0.08% of WealthShield Partners's portfolio in Q1 2026, its #215 holding.
  • WealthShield Partners first reported a position in Merck in Q4 2018 and has held it in 30 quarters since.
  • WealthShield Partners's Merck position peaked at $3.31M in Q1 2025.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on WealthShield Partners's 13F filing for Q1 2026, filed 1 May 2026.